2025.11.5 Article - Psychedelic-Assisted Therapy: A New Frontier in Mental-Health Care
In recent years, compounds once relegated to counter-culture status are now entering the medical spotlight as potential treatments for a range of challenging mental-health conditions. Substances such as Psilocybin (the active compound in “magic mushrooms”), MDMA (commonly known as ecstasy)-assisted therapy, and other psychedelics are being studied for their ability to address treatment-resistant depression, post-traumatic stress disorder (PTSD) and anxiety disorders.
For example, the Veterans Affairs (VA) has expanded clinical trials of psychedelic-assisted therapy across nine U.S. facilities to target veterans with PTSD and treatment-resistant depression. At the same time, states are passing legislation to accelerate study of psychedelic therapies — for instance, California recently enacted a bill to fast-track research for veterans
